An estimated 12% of worldwide cancer cases diagnosed in 2024 were linked directly to infections, according to a study published in The Lancet Oncology by the World Health Organization. The research tied 2.3 million new cancer diagnoses globally to specific pathogens, highlighting a major fraction of the disease burden that public health officials classify as preventable.
Global Cancer Burden Linked to Five Key Pathogens
The study found that the vast majority of infection-related malignancies stem from just five pathogens. Helicobacter pylori and human papillomavirus account for 4% each of total cases, hepatitis B contributes 2%, Epstein-Barr virus accounts for 1%, and hepatitis C drives under 1%. Together, these agents trigger more than 20 distinct types of cancer, including malignancies of the stomach, liver, cervix, and blood.
Biological Mechanisms Driving Viral and Bacterial Malignancies
Viruses and bacteria drive carcinogenesis through distinct biological pathways. Viruses can directly or indirectly alter host cell genes, causing cells to multiply uncontrollably. Viral pathogens frequently accomplish this by disabling cellular self-destruct mechanisms, such as inactivating the TP53 protein, or by turning off cell-cycle arrest proteins like RB. Certain viruses also insert their own DNA into host chromosomes, disrupting genes that regulate division, or carry pre-existing oncogenes acquired from other organisms.
In contrast, bacterial and parasitic infections operate more indirectly by triggering chronic inflammation and tissue stress. Long-term immune responses from pathogens like Helicobacter pylori or the liver fluke Opisthorchis viverrini damage local tissues. As the body attempts rapid repair, cells accumulate genetic mutations during division, setting the stage for tumor development.
Prevention and Vaccination Efforts
Because these malignancies originate from infectious agents, public health agencies emphasize that targeted interventions can significantly reduce case numbers. In Australia, the human papillomavirus immunization program initiated in 2007 drove a 90% drop in HPV infections among eligible adolescents, placing the country on a trajectory to eliminate cervical cancer by 2035. However, recent data show vaccination rates among 15-year-olds dropped from 85.7% in 2020 to 79.5% in 2024, falling short of the World Health Organization target to vaccinate 90% of targeted adolescents by 2030.
Keep reading